These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29035899)

  • 1. Driveline Site Is Not a Predictor of Infection After Ventricular Assist Device Implantation.
    Martin BJ; Luc JGY; Maruyama M; MacArthur R; Bates AR; Buchholz H; Freed DH; Conway J
    ASAIO J; 2018; 64(5):616-622. PubMed ID: 29035899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of chlorhexidine gluconate intolerance on driveline infection during chronic HeartMate II left ventricular assist device support.
    Son AY; Stein LH; DeAnda A; Katz SD; Smith DE; Reyentovich A; Balsam LB
    Int J Artif Organs; 2017 Jan; 39(11):570-574. PubMed ID: 28085173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Driveline Infection Risk with Utilization of a Temporary External Anchoring Suture After Implantation of a Left Ventricular Assist Device.
    Fudim M; Brown CL; Davis ME; Djunaidi M; Danter MR; Harrell FE; Stulak JM; Haglund NA; Maltais S
    ASAIO J; 2016; 62(3):291-6. PubMed ID: 26809083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Driveline Infection in Patients With Left Ventricular Assist Devices Implanted as Destination Therapy.
    Wasilewski G; Wiśniowska-Śmiałek S; Górkiewicz-Kot I; Milaniak I; Kaleta M; Hymczak H; Wasilewska A; Wierzbicki K
    Transplant Proc; 2024 May; 56(4):860-863. PubMed ID: 38734518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventricular Assist Device Driveline Infections: A Systematic Review.
    Krzelj K; Petricevic M; Gasparovic H; Biocina B; McGiffin D
    Thorac Cardiovasc Surg; 2022 Sep; 70(6):493-504. PubMed ID: 34521143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular assist device driveline infections in three contemporary devices.
    Schlöglhofer T; Michalovics P; Riebandt J; Angleitner P; Stoiber M; Laufer G; Schima H; Wiedemann D; Zimpfer D; Moscato F
    Artif Organs; 2021 May; 45(5):464-472. PubMed ID: 33052592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution and impact of drive-line infection in a large cohort of continuous-flow ventricular assist device recipients.
    Koval CE; Thuita L; Moazami N; Blackstone E
    J Heart Lung Transplant; 2014 Nov; 33(11):1164-72. PubMed ID: 25034793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing velour versus silicone interfaces at the driveline exit site of HeartMate II devices: infection rates, histopathology, and ultrastructural aspects.
    McCandless SP; Ledford ID; Mason NO; Alharethi R; Rasmusson BY; Budge D; Stoker SL; Clayson SE; Doty JR; Thomsen GE; Caine WT; Kfoury AG; Reid BB; Miller DV
    Cardiovasc Pathol; 2015; 24(2):71-5. PubMed ID: 25483742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and early treatment of driveline infections in ventricular assist device patients - The DESTINE staging proposal and the first standard of care protocol.
    Bernhardt AM; Schlöglhofer T; Lauenroth V; Mueller F; Mueller M; Schoede A; Klopsch C;
    J Crit Care; 2020 Apr; 56():106-112. PubMed ID: 31896443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanical Characterization of Anchoring Devices for the Prevention of Driveline Infection in Left Ventricular Assist Device Patients.
    Schachl J; Stoiber M; Socha M; Zimpfer D; Wiedemann D; Schima H; Schlöglhofer T
    ASAIO J; 2024 Apr; 70(4):249-256. PubMed ID: 38081043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Driveline infections in left ventricular assist devices: implications for destination therapy.
    Sharma V; Deo SV; Stulak JM; Durham LA; Daly RC; Park SJ; Baddour LM; Mehra K; Joyce LD
    Ann Thorac Surg; 2012 Nov; 94(5):1381-6. PubMed ID: 22818961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity Is Associated with Driveline Infection of Left Ventricular Assist Devices.
    Akay MH; Nathan SS; Radovancevic R; Poglajen G; Jezovnik MK; Candelaria IN; Averill BL; Patel MK; Kar B; Gregoric ID
    ASAIO J; 2019; 65(7):678-682. PubMed ID: 30398982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Driveline Infection in Left Ventricular Assist Device Patients: Effect of Standardized Protocols, Pathogen Type, and Treatment Strategy.
    Lumish HS; Cagliostro B; Braghieri L; Bohn B; Mondellini GM; Antler K; Feldman V; Kleet A; Murphy J; Tiburcio M; Fidlow K; Jennings D; Sayer GT; Takeda K; Naka Y; Demmer RT; Aaron JG; Uriel N; Colombo PC; Yuzefpolskaya M
    ASAIO J; 2022 Dec; 68(12):1450-1458. PubMed ID: 35239537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricle assist devices and driveline's infection incidence: a single-centre experience.
    Bejko J; Toto F; Gregori D; Gerosa G; Bottio T
    J Artif Organs; 2018 Mar; 21(1):52-60. PubMed ID: 28988400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of percutaneous driveline infection after left ventricular assist device implantation: prophylactic antibiotics are not necessary.
    Stulak JM; Maltais S; Cowger J; Joyce LD; Daly RC; Park SJ; Aaronson KD; Pagani FD
    ASAIO J; 2013; 59(6):570-4. PubMed ID: 24172262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Readmission due to driveline infection can be predicted by new score by using serum albumin and body mass index during long-term left ventricular assist device support.
    Imamura T; Kinugawa K; Nitta D; Inaba T; Maki H; Hatano M; Kinoshita O; Nawata K; Kyo S; Ono M
    J Artif Organs; 2015 Jun; 18(2):120-7. PubMed ID: 25604148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in driveline infection rates: Results from the HeartMate II Multicenter Driveline Silicone Skin Interface (SSI) Registry.
    Dean D; Kallel F; Ewald GA; Tatooles A; Sheridan BC; Brewer RJ; Caldeira C; Farrar DJ; Akhter SA;
    J Heart Lung Transplant; 2015 Jun; 34(6):781-9. PubMed ID: 25735901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical Polymyxin-Trimethoprim Prophylaxis May Decrease the Incidence of Driveline Infections in Patients With Continuous-Flow Left Ventricular Assist Devices.
    Durand ML; Ennis SC; Baker JN; Camuso JM; McEachern KM; Kotton CN; Lewis GD; Garcia JP; MacGillivray TE
    Artif Organs; 2017 Feb; 41(2):169-175. PubMed ID: 27098102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Driveline infections in left ventricular assist devices-Incidence, epidemiology, and staging proposal.
    Dettbarn E; Prenga M; Stein J; Müller M; Hoermandinger C; Schoenrath F; Falk V; Potapov E; Mulzer J; Knierim J
    Artif Organs; 2024 Jan; 48(1):83-90. PubMed ID: 37723833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.